We plan to collect health information from Australian patients with arthritis to monitor the benefits and safety of new treatments. All patients being treated with the new injectable biologic agents and other patients taking conventional drugs will be invited to take part in the follow up program. We will measure the impact of arthritis on quality of life and physical function and the long-term effects of all arthritis drugs. This will be of immense value to the Australian community as this data ....We plan to collect health information from Australian patients with arthritis to monitor the benefits and safety of new treatments. All patients being treated with the new injectable biologic agents and other patients taking conventional drugs will be invited to take part in the follow up program. We will measure the impact of arthritis on quality of life and physical function and the long-term effects of all arthritis drugs. This will be of immense value to the Australian community as this data are not routinely available from any other source. It will help rheumatologists and patients make the best decisions regarding long-term arthritis treatments.Read moreRead less
Characterisation and improvement of radiation beams used for radiotherapy of small lesions. This project aims to characterise the radiation dose from a medical linear accelerator after the beam has been shaped by a mini-multileaf collimator. The characterisation will be achieved through a combination of computer simulations and experimental investigation of the beam using the technique of three-dimensional gel dosimetry. When the dosage characteristics are known, techniques will be developed to ....Characterisation and improvement of radiation beams used for radiotherapy of small lesions. This project aims to characterise the radiation dose from a medical linear accelerator after the beam has been shaped by a mini-multileaf collimator. The characterisation will be achieved through a combination of computer simulations and experimental investigation of the beam using the technique of three-dimensional gel dosimetry. When the dosage characteristics are known, techniques will be developed to improve radiotherapy treatments in patients with small lesions with sizes of up to a few centimetres. This will lead to an improved outcome for some cancer patients.Read moreRead less
Antiviral compounds to inhibit the replicase of hepatitis C virus. Hepatitis C virus is a major public health problem. There are currently 200,000 infected individuals in Australia and 16,000 new infections every year. There is no specific treatment and current therapy treats a small percentage of patients only, which consists of interferon-alpha and ribavirin. This results in side effects and only a 50% cure rate. This study's outcomes are expected to lead to greater access to treatment and imp ....Antiviral compounds to inhibit the replicase of hepatitis C virus. Hepatitis C virus is a major public health problem. There are currently 200,000 infected individuals in Australia and 16,000 new infections every year. There is no specific treatment and current therapy treats a small percentage of patients only, which consists of interferon-alpha and ribavirin. This results in side effects and only a 50% cure rate. This study's outcomes are expected to lead to greater access to treatment and improved therapy resulting in higher cure rates and in a dramatic reduction in the cost of treating patients. A novel therapy will provide considerable benefits for the national biotechnology industry.Read moreRead less
Auditory and Vestibular Ringing--Detection and theraputic interventions. Tinnitus effects up to 30% of the elderly population. To date no single suppression modality has been successful across all tinnitus sufferers. This study will apply an aural, low level, modulated, fractal suppression strategy designed to induce a "natural" olivary efferent response capable of suppressing/reducing tinnitus.
Balance disorders e.g. Meniere's Disease and nausea (seasickness) are unwanted outcomes of vestibu ....Auditory and Vestibular Ringing--Detection and theraputic interventions. Tinnitus effects up to 30% of the elderly population. To date no single suppression modality has been successful across all tinnitus sufferers. This study will apply an aural, low level, modulated, fractal suppression strategy designed to induce a "natural" olivary efferent response capable of suppressing/reducing tinnitus.
Balance disorders e.g. Meniere's Disease and nausea (seasickness) are unwanted outcomes of vestibular dysfunction/hypersensitivity. This study will apply a low level, low frequency, modulated, acoustic pressure wave designed to induce a ?natural? olivary efferent response and an end organ endolymph/perilymph balance shift. It is postulated these stimuli will reduce the effects of vestibular dysfunction/hypersensitivity.
Read moreRead less
Epigenetic Therapies As Molecular Probes To Investigate The Molecular Pathogenesis Of Leukaemia
Funder
National Health and Medical Research Council
Funding Amount
$937,402.00
Summary
A major limitation to the success of targeted therapies in cancer is the fact that we have few if any tools to study in detail their mechanism of action within cancerous and normal cells. If we were able to visualise these drugs within cells and precisely characterise the proteins, DNA and RNA within a cell that interact with these therapies we will be able to identify strategies that can optimise their efficacy and reduce the side-effects of these treatments.
Defining targets and generating tools/therapeutic agents for prevention, diagnosis and therapy of atherothrombosis. Atherosclerosis and its complications such as myocardial infarction and stroke are a major cause of death and disability in Australia and worldwide. The proposed research program investigates new therapeutic targets and concepts (e.g. targeting of stem cells) to treat atherosclerosis and aims to develop new therapeutic agents using modern biotechnological methods. The project furth ....Defining targets and generating tools/therapeutic agents for prevention, diagnosis and therapy of atherothrombosis. Atherosclerosis and its complications such as myocardial infarction and stroke are a major cause of death and disability in Australia and worldwide. The proposed research program investigates new therapeutic targets and concepts (e.g. targeting of stem cells) to treat atherosclerosis and aims to develop new therapeutic agents using modern biotechnological methods. The project further aims to develop nanoparticle-based diagnostic tools to identify and preventatively treat atherosclerotic plaques that are prone to cause myocardial infarction. The expected outcome will provide direct benefit to patients and create new economic opportunities in Australian bio-/nanotechnology.Read moreRead less
Targeting genes elevated in the athlete's heart to improve function of the failing heart. Cardiovascular disease affects about 3.7 million Australians and heart failure ranks as one of the major killers, representing a huge burden on our health care system and economy. This situation is likely to get worse with an increasing ageing population. Current therapeutics for heart failure patients largely delay disease progression but generally fail in significantly improving heart function and quality ....Targeting genes elevated in the athlete's heart to improve function of the failing heart. Cardiovascular disease affects about 3.7 million Australians and heart failure ranks as one of the major killers, representing a huge burden on our health care system and economy. This situation is likely to get worse with an increasing ageing population. Current therapeutics for heart failure patients largely delay disease progression but generally fail in significantly improving heart function and quality of life. The proposal has focused on targeting the protective effects of 'good' heart growth by identifying genes elevated in the heart in response to exercise. Targeting genes elevated in the athlete's heart to improve function of the failing heart represents a new strategy for the treatment of heart failure.Read moreRead less
Design and Development of a Low-Cost Portable Biofeedback Device for use in Sleep Induction and Relaxation. This project aims to expand on existing knowledge of the various stimuli used in sleep induction such as photic, auditory and weak electromagnetic stimulation and develop a low-cost portable biofeedback prototype. This novel device will be based on adaptive or fuzzy reasoning algorithms, which would be integrated into the existing ambulatory Siesta EEG recording system, produced by Compume ....Design and Development of a Low-Cost Portable Biofeedback Device for use in Sleep Induction and Relaxation. This project aims to expand on existing knowledge of the various stimuli used in sleep induction such as photic, auditory and weak electromagnetic stimulation and develop a low-cost portable biofeedback prototype. This novel device will be based on adaptive or fuzzy reasoning algorithms, which would be integrated into the existing ambulatory Siesta EEG recording system, produced by Compumedics Ltd. The development of this novel real-time biofeedback prototype will encourage further research using this particular technology to apply it in preventative healthcare in Australian community. The outcome of this proposed bioinstrumentation prototype could possibly expand sleep market to new international level.Read moreRead less
Influence of an innovative shoe design on lower limb joint loading during walking. This project will provide new knowledge about the effects of shoe design features on lower limb loading and the influence of obesity and knee condition on the shoe-mediated biomechanical effects. This will be of relevance to researchers and clinicians. It is also likely to contribute to a marketable commercial product, a shoe designed to reduce knee loading. This shoe has the potential to contribute to reducing th ....Influence of an innovative shoe design on lower limb joint loading during walking. This project will provide new knowledge about the effects of shoe design features on lower limb loading and the influence of obesity and knee condition on the shoe-mediated biomechanical effects. This will be of relevance to researchers and clinicians. It is also likely to contribute to a marketable commercial product, a shoe designed to reduce knee loading. This shoe has the potential to contribute to reducing the societal and personal burden of knee osteoarthritis, one of the most prevalent and costly chronic conditions in the developed world. Read moreRead less
Combining PI3K, CDK4/6 Pathway Inhibitors And Immunotherapies In Triple-negative Breast Cancer (TNBC): A Novel Therapy Combination
Funder
National Health and Medical Research Council
Funding Amount
$626,345.00
Summary
Triple-negative breast cancer (TNBC) has the worst prognosis of all breast cancer subtypes, classically affecting young women and characterized by a lack of effective therapies. We show that blocking both PI3K and CDK4/6 pathways together effectively reduces TNBC growth in mice and can enhance anti-tumour immune responses. We aim to understand how these drugs work together and if adding immunotherapy can improve responses. Our project could provide a new treatment approach for TNBC patients.